Brief: 2CureX's Clinical Trial Meets Primary Endpoint

2cureX AB

01/03/2021 12:28

March 1 (Reuters) - 2cureX AB  2CUREX.ST :
    * 2CUREX ANNOUNCES THAT THE CLINICAL TRIAL OF
INDITREAT®-GUIDED
TREATMENT OF METASTATIC COLORECTAL CANCER HAS MET THE PRIMARY
ENDPOINT.

Source text for Eikon:  ID:nWkr1TkdcT 
Further company coverage:  2CUREX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))